Purpose

The goal of this clinical trial is to learn how reducing the nicotine content in filtered little cigars can affect the the use of these cigars and lung health in current adult filtered little cigar users. The main question[s] it aims to answer are: Are puffing behaviors, appeal/satisfaction, craving suppression, pharmacokinetic effects, and demand similar between the regular cigars smoked by participants, normal nicotine study cigars and very low nicotine study cigars? Are health effects and toxicant exposure similar between the regular cigars smoked by participants, normal nicotine study cigars and very low nicotine study cigars? Participants will attend three study visits at OSU. Each visit would last up to 4 hours. During visits, they will - fill several surveys - provide blood samples - perform breathing tests - complete smoking sessions using either their own cigars or the study cigars.

Condition

Eligibility

Eligible Ages
Between 21 Years and 75 Years
Eligible Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Smokers: 1) self-reported regular current filtered little cigars, cigarillos, little cigars, or small cigars use for the past 3 months; regular use will be defined as >=8 cigars smoked per month based on data showing median cigarillo use is 7.5 times per month and median FLC use is 14 times per month 59. We will attempt to bring in heavier users if feasible during recruitment; or 2) Dual-users: cigarette smokers (>=20d/month for at least 3 months) with co-use of filtered little cigars, cigarillos, little cigars, or small cigars (at least once in the past 3 months) - willing to abstain from all tobacco and nicotine for at least 12 hours prior to lab sessions - Willing to bring their own, preferred brand little cigars/ small cigars/ cigarillos/ filtered little cigars to smoke in the lab on the first study visit - capable of and willing to provide written informed consent - read and speak in English.

Exclusion Criteria

  • Self-reported significant current lung disease (e.g. asthma, COPD, cystic fibrosis, pulmonary fibrosis); exercise-induced asthma, seasonal allergies for which a patient takes inhalers are allowed - History of diagnosis or treatment for lung cancer - Self-reported serious or uncontrolled kidney disease, liver disease, metabolic disease (thyroid, diabetes) - History of cardiac event or distress within the past 3 months - Unstable or significant psychiatric conditions (past and stable conditions will be allowed) - Substance use disorders besides nicotine addiction - Regular use of other tobacco products besides cigarettes such as snuff, chewing tobacco, snus, e-cigarettes >10d per month - Exclusive large or premium cigar users - Zero use of filtered little cigars, cigarillos, little cigars, or small cigars in the past 3 months - Use of blunts every time or most of the time - Regular use of cannabis >10d per month - Planning to quit in next 30 days or currently trying to quit or quit attempt in past 30 days - Pregnant, delivery in past 12 weeks, breastfeeding, or planning to get pregnant - Inability to perform tests or follow instructions during testing

Study Design

Phase
Phase 4
Study Type
Interventional
Allocation
N/A
Intervention Model
Single Group Assignment
Primary Purpose
Basic Science
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Smoking session
All participants will undergo three smoking sessions: one using their own usual brand cigar, one with a normal nicotine study cigar, and one with a reduced nicotine study cigar
  • Drug: Reduced Nicotine Content Cigars
    Participants will smoke a very low nicotine content filtered little cigar containing 0.50mg nicotine per gram of tobacco
    Other names:
    • VLNFLC
  • Drug: Normal nicotine content cigar
    Participants will smoke a normal nicotine content filtered little cigar containing 5.17mg nicotine per gram of tobacco
    Other names:
    • FLC
  • Drug: Usual brand cigar
    Participants will smoke their usual brand filtered little cigar
    Other names:
    • UB

Recruiting Locations

The Ohio State University
Columbus, Ohio 43210
Contact:
Dharini M Bhammar, PhD, MBBS
614-366-9467
dharini.bhammar@osumc.edu

More Details

NCT ID
NCT06630728
Status
Recruiting
Sponsor
Ohio State University Comprehensive Cancer Center

Study Contact

Dharini M Bhammar, PhD, MBBS
614-366-9467
dharini.bhammar@osumc.edu

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.